Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma. - Wikidata - awgldk - TriplyDB

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.

http://www.wikidata.org/entity/Q34025829

about

Zinc finger proteins in cancer progression Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737 The Mutational Landscape of the Oncogenic MZF1 SCAN Domain in Cancer.ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion Transcription factors and cognate signalling cascades in the regulation of autophagy.C2H2 Zinc Finger Proteins: The Largest but Poorly Explored Family of Higher Eukaryotic Transcription Factors.The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.A novel SWIM domain protein ZSWIM5 inhibits the malignant progression of non-small-cell lung cancer ZNF259 promotes breast cancer cells invasion and migration via ERK/GSK3β/snail signaling ZKSCAN3 Upregulation and Its Poor Clinical Outcome in Uterine Cervical Cancer

P2860

Q26740525-F94879F3-351D-4E38-84FF-2C0F2B030216 Q28542684-B6148D0C-7F38-401B-8CAE-23D6D421B1D5 Q30396819-44B45F27-2613-40AE-A08F-0567C64A73C2 Q33888988-6EE11D6C-E682-4742-BF36-4999B8266BB4 Q33978937-684E07C8-96BE-479D-BEA6-A10D15DA2B3A Q36141838-CC237804-D847-46B1-B651-D1001038A1F3 Q37619797-8D074811-7FF2-46EA-8059-6F30F50F6222 Q38344277-BE642101-DFDF-458F-94B2-05166C603749 Q38663289-CC082E55-87B9-4BFF-86ED-11A8476D7B50 Q39359295-571EA64E-A535-4720-882C-9D2441D44F5C Q58764903-82ADD7C8-BE77-4D9F-B562-AB8A02A747F8 Q58767821-0286D570-2E83-4FFD-BABB-E0E2CB68B4AC Q59133895-437A5039-4C22-4B13-98F6-8326F7E81D29

P2860

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.

http://www.wikidata.org/entity/Q34025829

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evidence of a role for the nov ...... xpression in multiple myeloma.

@ast

Evidence of a role for the nov ...... xpression in multiple myeloma.

@en

Evidence of a role for the nov ...... xpression in multiple myeloma.

@nl

type

label

Evidence of a role for the nov ...... xpression in multiple myeloma.

@ast

Evidence of a role for the nov ...... xpression in multiple myeloma.

@en

Evidence of a role for the nov ...... xpression in multiple myeloma.

@nl

prefLabel

Evidence of a role for the nov ...... xpression in multiple myeloma.

@ast

Evidence of a role for the nov ...... xpression in multiple myeloma.

@en

Evidence of a role for the nov ...... xpression in multiple myeloma.

@nl

P1433

Q34025829-7ABF7914-EAB7-4341-8A17-54D355E24BE2

P1476

Q34025829-11FA8A43-A0F7-4C83-8FD3-E797D8A10847

P2093

Q34025829-05C66174-98C8-4F8B-A879-25C562A81CCD

Q34025829-2F52E174-1E72-4F02-8F2F-E27FEB801F0C

Q34025829-34EC03A0-B34A-4EA4-BF58-78C1C16E45EA

Q34025829-35093043-86B5-4DFF-A190-A2B040FE7B58

Q34025829-3982B46E-6110-4E21-85B0-22D5E9B6591E

Q34025829-3AFB7F97-98CC-466C-8AF9-D10C345E218C

Q34025829-3CD4353A-9A69-4191-9319-0D0F381F2133

Q34025829-5536EDEE-765A-434E-889A-2D3B097ADEAE

Q34025829-576EC175-E728-4AAF-9465-B51D7C972D1A

Q34025829-5E644811-41EB-45C5-8EDC-5DBA2848F681

P2860

Q34025829-163B9C4E-828D-4314-A28E-AABE232B2507

Q34025829-164D4F38-B5EF-4A08-A470-EDE02B1199E8

Q34025829-187219C1-6720-4A22-9336-372E4D24C3C0

Q34025829-2396C23F-CFAC-4A77-AD4C-EC3EAB009AAD

Q34025829-29566410-899B-4379-9C4D-11AEBBFFC8E5

Q34025829-2B8A70F3-CDE4-4A88-A8BC-AFB082EC1FF5

Q34025829-3B34A3AC-5B47-4F82-A7DE-18101442FED1

Q34025829-3EA47EA2-8875-4386-B8A4-222E30B49CFC

Q34025829-505F6727-9E9A-4E71-B4DC-9DB17BB5CEC1

Q34025829-79129FE1-C934-44CB-831D-1693A081CC60

P2888

Q34025829-423A7DC0-CEDB-4FEB-A561-0A939E49DBDC

P304

Q34025829-477F34D1-22DC-4E4F-B48A-32E7018F765F

P31

Q34025829-FD4CB114-2120-4FE1-8099-D328CFA48577

P356

Q34025829-6E4D5D88-9B01-462E-9879-450C730BB9D6

P407

Q34025829-5D660019-583A-4ED9-A059-3DBA5D788B58

P433

Q34025829-34F46A29-1BBF-4195-8982-AFADFC5EB228

P478

Q34025829-56C9DF28-BB51-4B37-BCFD-67AA5C96F7A1

P577

Q34025829-6711B076-E9A6-4043-95A8-549750FD1745

P5875

Q34025829-8BC464CA-EFE9-43C9-8FDC-5C324DBFA31B

P6179

Q34025829-52C7D2E7-E3DB-4819-ADBA-949DD003CE32

P698

Q34025829-456E2CB5-7BC3-4FFF-9585-10157AD5EB96

P932

Q34025829-8DE663E8-12F1-419F-B06D-7C12E4324A2F

P356

P1433

P1476

Evidence of a role for the nov ...... xpression in multiple myeloma.

@en

P2093

D A Graber

http://www.w3.org/2001/XMLSchema#string

D M Weber

http://www.w3.org/2001/XMLSchema#string

G Lu

http://www.w3.org/2001/XMLSchema#string

H Wang

http://www.w3.org/2001/XMLSchema#string

J A Matthews

http://www.w3.org/2001/XMLSchema#string

J J Shah

http://www.w3.org/2001/XMLSchema#string

K A Baggerly

http://www.w3.org/2001/XMLSchema#string

L Yang

http://www.w3.org/2001/XMLSchema#string

L Zhang

http://www.w3.org/2001/XMLSchema#string

M Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma

Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets

Multiple myeloma

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts

Chromosome 6p amplification and cancer progression.

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

Molecular pathogenesis and a consequent classification of multiple myeloma.

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma

P2888

P304

1329-1340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2010.515

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47701387

http://www.w3.org/2001/XMLSchema#string

P6179

1004462205

http://www.w3.org/2001/XMLSchema#string

P698

21057542

http://www.w3.org/2001/XMLSchema#string

P932

4128235

http://www.w3.org/2001/XMLSchema#string